178 related articles for article (PubMed ID: 35287671)
1. The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy/pyroptosis signaling pathway.
Zhu J; Wen Y; Zhang Q; Nie F; Cheng M; Zhao X
J Transl Med; 2022 Mar; 20(1):128. PubMed ID: 35287671
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis.
Chen X; Xue W; Zhang J; Peng J; Huang W
Lipids Health Dis; 2023 Feb; 22(1):22. PubMed ID: 36759837
[TBL] [Abstract][Full Text] [Related]
3. Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
Zhu J; Tang W; Wu X; Mu M; Zhang Q; Zhao X
Biochem Biophys Res Commun; 2024 Aug; 720():150118. PubMed ID: 38776757
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR22HG/microRNA-9-3p/IGF1 in nonalcoholic steatohepatitis, the ceRNA network increases fibrosis by inhibiting autophagy and promoting pyroptosis.
Chen X; Zhou S; Chen Y; Tong K; Huang W
Clin Nutr; 2024 Jan; 43(1):52-64. PubMed ID: 38011754
[TBL] [Abstract][Full Text] [Related]
5. Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway.
Qiu T; Pei P; Yao X; Jiang L; Wei S; Wang Z; Bai J; Yang G; Gao N; Yang L; Qi S; Yan R; Liu X; Sun X
Cell Death Dis; 2018 Sep; 9(10):946. PubMed ID: 30237538
[TBL] [Abstract][Full Text] [Related]
6. Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway.
Shi H; Qiao F; Lu W; Huang K; Wen Y; Ye L; Chen Y
Eur J Pharmacol; 2022 Nov; 934():175270. PubMed ID: 36184988
[TBL] [Abstract][Full Text] [Related]
7. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy.
Zhang N; Wu Y; Zhong W; Xia G; Xia H; Wang L; Wei X; Li Y; Shang H; He H; Lin S
Phytomedicine; 2022 Jul; 102():154148. PubMed ID: 35576742
[TBL] [Abstract][Full Text] [Related]
8. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
9. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes.
Zhuge Q; Zhang Y; Liu B; Wu M
Ann Palliat Med; 2020 May; 9(3):1045-1054. PubMed ID: 32389004
[TBL] [Abstract][Full Text] [Related]
10. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
11. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
12. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
[TBL] [Abstract][Full Text] [Related]
13. A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy.
Zhu J; Cheng M; Zhao X
Life Sci; 2020 Sep; 257():118125. PubMed ID: 32702444
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of HucMSCs, exosomes, and conditioned medium on NASH.
Liang C; Gao S; Gao J; Xu Y; Li Q
Sci Rep; 2023 Oct; 13(1):18431. PubMed ID: 37891247
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
[TBL] [Abstract][Full Text] [Related]
17. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis.
Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L
J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
Koh EH; Yoon JE; Ko MS; Leem J; Yun JY; Hong CH; Cho YK; Lee SE; Jang JE; Baek JY; Yoo HJ; Kim SJ; Sung CO; Lim JS; Jeong WI; Back SH; Baek IJ; Torres S; Solsona-Vilarrasa E; Conde de la Rosa L; Garcia-Ruiz C; Feldstein AE; Fernandez-Checa JC; Lee KU
Gut; 2021 Oct; 70(10):1954-1964. PubMed ID: 33208407
[TBL] [Abstract][Full Text] [Related]
19. Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.
Liu Y; Wang DW; Wang D; Duan BH; Kuang HY
Front Endocrinol (Lausanne); 2021; 12():663039. PubMed ID: 33953700
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
